HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Single resting hsTnT level predicts abnormal myocardial stress test in acute chest pain patients with normal initial standard troponin.

AbstractOBJECTIVES:
The goal of this study was to determine the ability of a single, resting high-sensitivity troponin T (hsTnT) measurement to predict abnormal myocardial perfusion imaging (MPI) in patients presenting with acute chest pain to the emergency department (ED).
BACKGROUND:
HsTnT assays precisely detect very low levels of troponin T, which may be a surrogate for the presence and extent of myocardial ischemia.
METHODS:
We included all patients from the ROMICAT I (Rule Out Myocardial Infarction Using Computer Assisted Tomography) trial, an observational cohort study, who underwent both single-photon emission computed tomography (SPECT)-MPI stress testing and 64-slice computed tomography angiography (CTA) and in whom hsTnT measurements were available. We assessed the discriminatory value of hsTnT for abnormal SPECT-MPI and the association of reversible myocardial ischemia by SPECT-MPI and the extent of coronary atherosclerosis by CTA to hsTnT levels.
RESULTS:
Of the 138 patients (mean age 54 ± 11 years, 46% male), 19 (13.7%) had abnormal SPECT-MPI. Median hsTnT levels were significantly different between patients with normal and abnormal SPECT-MPI (9.41 pg/ml [interquartile range (IQR): 5.73 to 19.20 pg/ml] vs. 4.89 pg/ml [IQR: 2.34 to 7.68 pg/ml], p = 0.001). Sensitivity of 80% and 90% to detect abnormal SPECT-MPI was reached at hsTnT levels as low as 5.73 and 4.26 pg/ml, respectively. Corresponding specificity was 62% and 46%, and negative predictive value was 96% and 96%, respectively. HsTnT levels had good discriminatory ability for prediction of abnormal SPECT-MPI (area under the curve: 0.739, 95% confidence interval: 0.609 to 0.868). Both reversible myocardial ischemia and the extent of coronary atherosclerosis (combined model r(2) = 0.19 with partial of r(2) = 0.12 and r(2) = 0.05, respectively) independently and incrementally predicted the measured hsTnT levels.
CONCLUSIONS:
In patients with acute chest pain, myocardial perfusion abnormalities and coronary artery disease are predicted by resting hsTnT levels. Prospective evaluations are warranted to confirm whether resting hsTnT could serve as a powerful triage tool in chest pain patients in the ED before diagnostic testing and improve the effectiveness of patient management.
AuthorsWaleed Ahmed, Christopher L Schlett, Shanmugam Uthamalingam, Quynh A Truong, Wolfgang Koenig, Ian S Rogers, Ron Blankstein, John T Nagurney, Ahmed Tawakol, James L Januzzi, Udo Hoffmann
JournalJACC. Cardiovascular imaging (JACC Cardiovasc Imaging) Vol. 6 Issue 1 Pg. 72-82 (Jan 2013) ISSN: 1876-7591 [Electronic] United States
PMID23328564 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Biomarkers
  • Troponin T
Topics
  • Acute Disease
  • Adult
  • Aged
  • Angina Pectoris (blood, diagnosis, physiopathology)
  • Biomarkers (blood)
  • Coronary Angiography (methods)
  • Coronary Artery Disease (blood, diagnosis, physiopathology)
  • Cross-Sectional Studies
  • Discriminant Analysis
  • Emergency Service, Hospital
  • Female
  • Humans
  • Linear Models
  • Logistic Models
  • Male
  • Middle Aged
  • Multidetector Computed Tomography
  • Multivariate Analysis
  • Myocardial Ischemia (blood, diagnosis, physiopathology)
  • Myocardial Perfusion Imaging (methods)
  • Predictive Value of Tests
  • Sensitivity and Specificity
  • Tomography, Emission-Computed, Single-Photon
  • Troponin T (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: